Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. Pathology / 病理學科所
  4. Dystrophin is a tumor suppressor in human cancers with myogenic programs
 
  • Details

Dystrophin is a tumor suppressor in human cancers with myogenic programs

Journal
Nature Genetics
Journal Volume
46
Journal Issue
6
Pages
601-606
Date Issued
2014
Author(s)
Wang Y.
Marino-Enriquez A.
Bennett R.R.
Zhu M.
Shen Y.
Eilers G.
JEN-CHIEH LEE  
Henze J.
Fletcher B.S.
Gu Z.
Fox E.A.
Antonescu C.R.
Fletcher C.D.M.
Guo X.
Raut C.P.
Demetri G.D.
Van De Rijn M.
Ordog T.
Kunkel L.M.
Fletcher J.A.
DOI
10.1038/ng.2974
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901680208&doi=10.1038%2fng.2974&partnerID=40&md5=5f1a2de05b1cbdbecb48ecbf4c2944af
https://scholars.lib.ntu.edu.tw/handle/123456789/473706
Abstract
Many common human mesenchymal tumors, including gastrointestinal stromal tumor (GIST), rhabdomyosarcoma (RMS) and leiomyosarcoma (LMS), feature myogenic differentiation. Here we report that intragenic deletion of the dystrophin-encoding and muscular dystrophy-associated DMD gene is a frequent mechanism by which myogenic tumors progress to high-grade, lethal sarcomas. Dystrophin is expressed in the non-neoplastic and benign counterparts of GIST, RMS and LMS tumors, and DMD deletions inactivate larger dystrophin isoforms, including 427-kDa dystrophin, while preserving the expression of an essential 71-kDa isoform. Dystrophin inhibits myogenic sarcoma cell migration, invasion, anchorage independence and invadopodia formation, and dystrophin inactivation was found in 96%, 100% and 62% of metastatic GIST, embryonal RMS and LMS samples, respectively. These findings validate dystrophin as a tumor suppressor and likely anti-metastatic factor, suggesting that therapies in development for muscular dystrophies may also have relevance in the treatment of cancer. ? 2014 Nature America, Inc.
SDGs

[SDGs]SDG3

Other Subjects
dystrophin; anchorage independent growth; article; cell invasion; cell migration; clinical article; controlled study; embryonal rhabdomyosarcoma; female; fluorescence in situ hybridization; gastrointestinal stromal tumor; gene deletion; gene expression; gene inactivation; human; human cell; human tissue; leiomyosarcoma; male; multiplex ligation dependent probe amplification; muscular dystrophy; nucleotide sequence; priority journal; sarcoma cell; single nucleotide polymorphism; transcription initiation site; tumor suppressor gene; X chromosome; Animals; Cell Differentiation; Cell Line, Tumor; Cell Movement; Disease Progression; Dystrophin; Female; Gastrointestinal Stromal Tumors; Gene Deletion; Genes, Tumor Suppressor; Humans; In Situ Hybridization, Fluorescence; Interstitial Cells of Cajal; Leiomyosarcoma; Male; Mice; Mice, Inbred BALB C; Muscle Development; Muscle, Skeletal; Muscular Dystrophies; Neoplasm Invasiveness; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Rhabdomyosarcoma; Sarcoma
Publisher
Nature Publishing Group
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science